Moreover, ACE inhibitors and angiotensin II receptor blockers may reduce levodopa-induced dyskinesia occurrence in PD patients with hypertension [126], and the use of ACE inhibitors has been linked to a reduced number of falls in these patients [127]. The gene discussed is ACE; the disease is Dyskinesia.